The absence of CD4+ T cell count recovery despite receipt of virologically suppressive highly active antiretroviral therapy: clinical risk, immunological gaps, and therapeutic options

Up to 30% of human immunodeficiency virus (HIV)-infected patients who are receiving long-term highly active antiretroviral therapy do not exhibit a marked increase in the CD4(+) T cell count, despite achieving complete suppression of the HIV load. These patients are referred to as "immunologica...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clinical infectious diseases Ročník 48; číslo 3; s. 328
Hlavní autoři: Gazzola, Lidia, Tincati, Camilla, Bellistrì, Giusi Maria, Monforte, Antonella d'Arminio, Marchetti, Giulia
Médium: Journal Article
Jazyk:angličtina
Vydáno: United States 01.02.2009
Témata:
ISSN:1537-6591, 1537-6591
On-line přístup:Zjistit podrobnosti o přístupu
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Up to 30% of human immunodeficiency virus (HIV)-infected patients who are receiving long-term highly active antiretroviral therapy do not exhibit a marked increase in the CD4(+) T cell count, despite achieving complete suppression of the HIV load. These patients are referred to as "immunological nonresponders." When treating immunological nonresponders, the practicing clinician has several questions, including questions about the clinical risk associated with persistent immunodeficiency and about possible approaches to treatment that would provide clinical and immunological benefits. However, tentative answers to these questions require investigations of the mechanisms that underlie the lack of immune recovery, because only the deepest comprehension of the immunological gaps underlying functional defects will allow administration of highly targeted and efficacious treatment strategies. The aim of our review is to provide a thorough assessment of the clinical implications of a lack of increase in the CD4(+) T cell count in immunological nonresponders, to examine the immunological gaps limiting recovery of the CD4(+) T cell count, and to note possible therapeutic avenues, which may offer clinicians guidance regarding how to most efficaciously treat these critical patients.
AbstractList Up to 30% of human immunodeficiency virus (HIV)-infected patients who are receiving long-term highly active antiretroviral therapy do not exhibit a marked increase in the CD4(+) T cell count, despite achieving complete suppression of the HIV load. These patients are referred to as "immunological nonresponders." When treating immunological nonresponders, the practicing clinician has several questions, including questions about the clinical risk associated with persistent immunodeficiency and about possible approaches to treatment that would provide clinical and immunological benefits. However, tentative answers to these questions require investigations of the mechanisms that underlie the lack of immune recovery, because only the deepest comprehension of the immunological gaps underlying functional defects will allow administration of highly targeted and efficacious treatment strategies. The aim of our review is to provide a thorough assessment of the clinical implications of a lack of increase in the CD4(+) T cell count in immunological nonresponders, to examine the immunological gaps limiting recovery of the CD4(+) T cell count, and to note possible therapeutic avenues, which may offer clinicians guidance regarding how to most efficaciously treat these critical patients.
Up to 30% of human immunodeficiency virus (HIV)-infected patients who are receiving long-term highly active antiretroviral therapy do not exhibit a marked increase in the CD4(+) T cell count, despite achieving complete suppression of the HIV load. These patients are referred to as "immunological nonresponders." When treating immunological nonresponders, the practicing clinician has several questions, including questions about the clinical risk associated with persistent immunodeficiency and about possible approaches to treatment that would provide clinical and immunological benefits. However, tentative answers to these questions require investigations of the mechanisms that underlie the lack of immune recovery, because only the deepest comprehension of the immunological gaps underlying functional defects will allow administration of highly targeted and efficacious treatment strategies. The aim of our review is to provide a thorough assessment of the clinical implications of a lack of increase in the CD4(+) T cell count in immunological nonresponders, to examine the immunological gaps limiting recovery of the CD4(+) T cell count, and to note possible therapeutic avenues, which may offer clinicians guidance regarding how to most efficaciously treat these critical patients.Up to 30% of human immunodeficiency virus (HIV)-infected patients who are receiving long-term highly active antiretroviral therapy do not exhibit a marked increase in the CD4(+) T cell count, despite achieving complete suppression of the HIV load. These patients are referred to as "immunological nonresponders." When treating immunological nonresponders, the practicing clinician has several questions, including questions about the clinical risk associated with persistent immunodeficiency and about possible approaches to treatment that would provide clinical and immunological benefits. However, tentative answers to these questions require investigations of the mechanisms that underlie the lack of immune recovery, because only the deepest comprehension of the immunological gaps underlying functional defects will allow administration of highly targeted and efficacious treatment strategies. The aim of our review is to provide a thorough assessment of the clinical implications of a lack of increase in the CD4(+) T cell count in immunological nonresponders, to examine the immunological gaps limiting recovery of the CD4(+) T cell count, and to note possible therapeutic avenues, which may offer clinicians guidance regarding how to most efficaciously treat these critical patients.
Author Bellistrì, Giusi Maria
Tincati, Camilla
Gazzola, Lidia
Monforte, Antonella d'Arminio
Marchetti, Giulia
Author_xml – sequence: 1
  givenname: Lidia
  surname: Gazzola
  fullname: Gazzola, Lidia
  organization: Department of Medicine, Surgery, and Dentistry, Clinic of Infectious Diseases, San Paolo Hospital, University of Milan, Milan, Italy
– sequence: 2
  givenname: Camilla
  surname: Tincati
  fullname: Tincati, Camilla
– sequence: 3
  givenname: Giusi Maria
  surname: Bellistrì
  fullname: Bellistrì, Giusi Maria
– sequence: 4
  givenname: Antonella d'Arminio
  surname: Monforte
  fullname: Monforte, Antonella d'Arminio
– sequence: 5
  givenname: Giulia
  surname: Marchetti
  fullname: Marchetti, Giulia
BackLink https://www.ncbi.nlm.nih.gov/pubmed/19123868$$D View this record in MEDLINE/PubMed
BookMark eNpNkM1OwzAQhC1URH-AR0A-caGFOImdhBsqv1IlLuVcbZ1Na0hsYzuV-mS8HoloJU47O_pmDjMmA200EnLJolsW5eKOFzzn7ISMGE-ymeAFG_zTQzL2_jOKGMsjfkaGrGBxkot8RH6WW6Sw9qglUlPR-WN6Q5dUYl1TaVodqENpduj2tERvVcDeQGVDT--UM7XZKAl1vae-tdah92qHdKs2284CGfoPdFAOgzNdAGoatujA7u-prJXuw9Qp_zWlqmlafSykG7B-2kXLA49tUJIaG5TR_pycVlB7vDjcCfl4flrOX2eL95e3-cNiJhMuwiypMgapLIoqYQw7mWZpATyOgUNcijLjwIQoY8wg7_6ilHHZjVNAlgiOgPGEXP_1Wme-W_Rh1SjfrwMaTetXQuQR47nowKsD2K4bLFfWqQbcfnWcOv4Fz9WExA
CitedBy_id crossref_primary_10_1186_s12967_015_0601_2
crossref_primary_10_1002_sim_3725
crossref_primary_10_1186_1471_2334_10_318
crossref_primary_10_1371_journal_pone_0219201
crossref_primary_10_3389_fimmu_2022_1066036
crossref_primary_10_1089_aid_2010_0086
crossref_primary_10_1093_infdis_jiz185
crossref_primary_10_1517_14712598_2013_779251
crossref_primary_10_1186_s13104_016_1991_9
crossref_primary_10_1186_1745_6215_15_390
crossref_primary_10_1016_j_atherosclerosis_2014_08_054
crossref_primary_10_1586_1744666X_2013_842897
crossref_primary_10_1371_journal_pone_0217742
crossref_primary_10_3389_fimmu_2019_00233
crossref_primary_10_3389_fimmu_2022_869286
crossref_primary_10_1186_1471_2334_11_343
crossref_primary_10_1517_17425255_2014_854330
crossref_primary_10_3389_fmicb_2022_1004960
crossref_primary_10_1155_2012_515962
crossref_primary_10_2147_HIV_S483094
crossref_primary_10_4102_sajhivmed_v20i1_1013
crossref_primary_10_1089_aid_2009_0263
crossref_primary_10_1177_15598276221078222
crossref_primary_10_1155_2012_935425
crossref_primary_10_1089_aid_2013_0097
crossref_primary_10_3389_fmolb_2021_809085
crossref_primary_10_1186_s12977_016_0261_1
crossref_primary_10_1186_1471_2172_14_26
crossref_primary_10_1089_aid_2012_0192
crossref_primary_10_1128_JVI_00571_15
crossref_primary_10_1186_1471_2334_12_14
crossref_primary_10_1186_s12865_019_0317_9
crossref_primary_10_3389_fimmu_2021_796898
crossref_primary_10_1186_1471_2334_11_43
crossref_primary_10_1186_s12979_019_0166_7
crossref_primary_10_1586_17476348_2016_1157474
crossref_primary_10_1186_1471_2172_15_2
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1086/595851
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1537-6591
ExternalDocumentID 19123868
Genre Research Support, Non-U.S. Gov't
Journal Article
Review
GroupedDBID ---
..I
.2P
.I3
.ZR
08P
0R~
1TH
29B
2AX
2WC
36B
4.4
48X
53G
5GY
5RE
5VS
5WD
6J9
AABZA
AACGO
AACZT
AAJKP
AAJQQ
AAMVS
AANCE
AAOGV
AAPQZ
AAPXW
AAQQT
AARHZ
AAUAY
AAUQX
AAVAP
AAYOK
ABBHK
ABDFA
ABEJV
ABEUO
ABGNP
ABIXL
ABJNI
ABLJU
ABNGD
ABNHQ
ABOCM
ABPLY
ABPQP
ABPTD
ABQLI
ABQNK
ABTLG
ABVGC
ABWST
ABXSQ
ABXVV
ACGFO
ACGFS
ACHIC
ACPRK
ACUFI
ACUKT
ACUTJ
ACUTO
ACYHN
ADBBV
ADGZP
ADHKW
ADHZD
ADIPN
ADNBA
ADQBN
ADQXQ
ADRTK
ADULT
ADVEK
ADYVW
ADZXQ
AEGPL
AEGXH
AEJOX
AEKSI
AEMDU
AEMQT
AENEX
AENZO
AEPUE
AETBJ
AEUPB
AEWNT
AEXZC
AFFNX
AFFZL
AFIYH
AFOFC
AFRAH
AFXAL
AGINJ
AGQXC
AGSYK
AGUTN
AHMBA
AHMMS
AHXPO
AIAGR
AJEEA
AJNCP
ALMA_UNASSIGNED_HOLDINGS
ALUQC
ALXQX
APIBT
APWMN
AQKUS
AQVQM
ASPBG
ATGXG
AVWKF
AXUDD
AZFZN
BAWUL
BAYMD
BCRHZ
BEYMZ
BHONS
BTRTY
BVRKM
C1A
C45
CDBKE
CGR
CS3
CUY
CVF
CZ4
DAKXR
DCCCD
DIK
DILTD
DU5
D~K
E3Z
EBS
ECM
EE~
EIF
EJD
EMOBN
ENERS
F5P
F9B
FECEO
FEDTE
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
H13
H5~
HAR
HTVGU
HVGLF
HW0
HZ~
IOX
IPSME
J21
JAAYA
JBMMH
JENOY
JHFFW
JKQEH
JLS
JLXEF
JPM
JSG
JST
JXSIZ
KAQDR
KBUDW
KOP
KSI
KSN
L7B
M49
MHKGH
MJL
ML0
N4W
N9A
NGC
NOMLY
NOYVH
NPM
NU-
NVLIB
O0~
O9-
OAUYM
OAWHX
OCZFY
ODMLO
ODZKP
OJQWA
OJZSN
OK1
OPAEJ
OVD
OWPYF
P2P
P6G
PAFKI
PB-
PEELM
PQQKQ
Q1.
Q5Y
QBD
RD5
ROX
ROZ
RUSNO
RW1
RXO
SA0
SJN
TCURE
TEORI
TJX
TMA
TR2
W8F
X7H
YAYTL
YKOAZ
YXANX
~91
~S-
7X8
AGQPQ
AJBYB
ID FETCH-LOGICAL-c356t-3f71a4c99f311e1a44749a522a5a2d6d75a166d2e7a82d69dc2d1919a7365eae2
IEDL.DBID 7X8
ISICitedReferencesCount 183
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000262291200010&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1537-6591
IngestDate Thu Oct 02 09:49:24 EDT 2025
Thu Apr 03 07:04:40 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 3
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c356t-3f71a4c99f311e1a44749a522a5a2d6d75a166d2e7a82d69dc2d1919a7365eae2
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
PMID 19123868
PQID 66801586
PQPubID 23479
ParticipantIDs proquest_miscellaneous_66801586
pubmed_primary_19123868
PublicationCentury 2000
PublicationDate 2009-02-01
PublicationDateYYYYMMDD 2009-02-01
PublicationDate_xml – month: 02
  year: 2009
  text: 2009-02-01
  day: 01
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Clinical infectious diseases
PublicationTitleAlternate Clin Infect Dis
PublicationYear 2009
SSID ssj0011805
Score 2.3969836
SecondaryResourceType review_article
Snippet Up to 30% of human immunodeficiency virus (HIV)-infected patients who are receiving long-term highly active antiretroviral therapy do not exhibit a marked...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 328
SubjectTerms Antiretroviral Therapy, Highly Active
CD4 Lymphocyte Count
CD4-Positive T-Lymphocytes - immunology
HIV Infections - drug therapy
HIV Infections - immunology
Humans
Treatment Outcome
Viral Load
Title The absence of CD4+ T cell count recovery despite receipt of virologically suppressive highly active antiretroviral therapy: clinical risk, immunological gaps, and therapeutic options
URI https://www.ncbi.nlm.nih.gov/pubmed/19123868
https://www.proquest.com/docview/66801586
Volume 48
WOSCitedRecordID wos000262291200010&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1La9wwEBZpE0ovzaOPpHnNIbdE1LZeVimUkgc9NEsOCezNyJJcFsp6u3YC-8vy9zrjB8ml9NCDjS0sW3hGn0aa-TSMnahSxujLiufBSS5j5TlOI0qujPVJUpYiVN2W-T_MZJJPp_ZmjX0ZuTAUVjliYgfUofa0Rv5Ja8RSleuvi9-cckaRb3VIoPGCrQs0ZCigy0yffAhp3gUwYpc2XCubPssspCx5w_5uVHaDy9Xm_zVri70ZjEr41mvBNluL8x326npwm79lj6gM4MqGejHUFZxfyFO4BVq0hy5ZBNC8GJV6BYFc722kgohwQk8TE25AyF8raO4XfezsQwTa6xiLXIeZgDJC_GxpjWKJremZXavPMJIvgcLYz2BGjJTxhfDTLZozrBrgGRMM6j7U5h27u7q8Pf_Oh4wN3AulWy4qkzrpra1Emka8lEZahyaeUy4LOhjlUq1DFo3L8d4GnwWcMFpnhFbRxew9ezmv53GXgVeZizIRpQ5R4mETJ8os99aJiuj7e-x4FEiBPYL-mJvH-r4pRpHssQ-9TItFv3FHgZ9CC0XnH_9Zd5-97t1GFLdywNYrxIJ4yDb8QztrlkedouF5cnP9B-Gv47o
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+absence+of+CD4%2B+T+cell+count+recovery+despite+receipt+of+virologically+suppressive+highly+active+antiretroviral+therapy%3A+clinical+risk%2C+immunological+gaps%2C+and+therapeutic+options&rft.jtitle=Clinical+infectious+diseases&rft.au=Gazzola%2C+Lidia&rft.au=Tincati%2C+Camilla&rft.au=Bellistr%C3%AC%2C+Giusi+Maria&rft.au=Monforte%2C+Antonella+d%27Arminio&rft.date=2009-02-01&rft.eissn=1537-6591&rft.volume=48&rft.issue=3&rft.spage=328&rft_id=info:doi/10.1086%2F595851&rft_id=info%3Apmid%2F19123868&rft_id=info%3Apmid%2F19123868&rft.externalDocID=19123868
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1537-6591&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1537-6591&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1537-6591&client=summon